Author:
Roman-González Alejandro,Vásquez Paola Jiménez,Hyde Samuel Mayer,Jessop Aaron C.,Jimenez Camilo
Publisher
Springer International Publishing
Reference131 articles.
1. DeLellis RA, International Agency for Research on Cancer; World Health Organization; International Academy of Pathology; International Association for the Study of Lung Cancer. Pathology and genetics of tumors of endocrine organs. Lyon: IARCS Press; 2004.
2. Wachtel H, Cerullo I, Bartlett EK, Roses RE, Cohen DL, Kelz RR, et al. Clinicopathologic characteristics of incidentally identified pheochromocytoma. Ann Surg Oncol. 2015;22(1):132–8.
3. Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011;96(3):717–25.
4. Ayala-Ramirez M, Palmer JL, Hofmann MC, de la Cruz M, Moon BS, Waguespack SG, et al. Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma. J Clin Endocrinol Metab. 2013;98(4):1492–7.
5. Parghane RV, Basher RK, Vatsa R, Shukla J, Bhattacharya A, Mittal BR. Breast metastasis detected on Ga-68 DOTATATE positron emission tomography/computed tomography imaging in malignant pheochromocytoma. World J Nucl Med. 2015;14(1):69–70.